Document:

EX-10.8

August 3, 2005

Naturade, Inc. (the “Company”)

14370 Myford Road, Suite 100

Irvine, CA 92606

Re: David Brown, (the “Holder”)

Gentlemen:

The undersigned is an owner of record or beneficially of certain shares of common stock
(“Common Stock”) of the Company or securities convertible into or exchangeable or exercisable for
Common Stock. The Company proposes to enter into a transaction with the Company (the
“Transaction”). The undersigned recognizes that the Transaction will be of benefit to the
undersigned and will benefit the Company. The undersigned acknowledges that the Company is relying
on the representations and agreements of the undersigned contained in this letter agreement in
carrying out the Transaction.

In consideration of the foregoing, the undersigned hereby agrees that the undersigned will
not, (and will cause any immediate family member of (i) the undersigned or (ii) the undersigned’s
spouse, living in the undersigned’s household not to), without the prior written consent of the
Company (which consent may be withheld in its sole discretion), directly or indirectly, sell,
offer, contract or grant any option to sell (including without limitation any short sale), pledge,
transfer, establish an open “put equivalent position” within the meaning of Rule 16a-1(h) under the
Securities Exchange Act of 1934, as amended, or otherwise dispose of any shares of Common Stock,
options or warrants to acquire shares of Common Stock, or securities exchangeable or exercisable
for or convertible into shares of Common Stock currently or hereafter owned either of record or
beneficially (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) by
the undersigned (or such spouse or family member), or publicly announce an intention to do any of
the foregoing, for a period of three hundred and sixty-five (365) days from the closing date of the
Transaction.  The foregoing sentence shall not apply to the transfer of any or all
shares of Common Stock owned by the undersigned, either during his or her lifetime or on death, by
gift, will or intestate succession to the immediate family of the undersigned or to a trust the
beneficiaries of which are exclusively the undersigned and/or a member or members of his or her
immediate family; provided, however, that in any such case it shall be a condition to such transfer
that the transferee executes and delivers to The Company an agreement stating that the transferee
is receiving and holding the Common Stock subject to the provisions of this letter agreement, and
there shall be no further transfer of such Common Stock except in accordance with this letter
agreement. The undersigned also agrees and consents to the entry of stop transfer instructions with
the Company’s transfer agent and registrar against the transfer of shares of Common Stock or
securities convertible into or exchangeable or exercisable for Common Stock held by the undersigned
except in compliance with the foregoing restrictions. For purposes of this paragraph, the term
“immediate family” shall have the same meaning as set forth in Rule 16a-1(e) promulgated under the
Securities Exchange Act of 1934, as amended.

This letter agreement is irrevocable and will be binding on the undersigned and the respective
successors, heirs, personal representatives and assigns of the undersigned.

David Brown

Printed Name of Holder

By: /s/David Brown

	 	 	 	Signature

Printed Name of Person Signing

(and indicate capacity of person signing if

signing as custodian, trustee, or on behalf

of an entity)EX-10.9

TRADEMARK LICENSE AGREEMENT

This Trademark License Agreement (“Agreement”) is entered into as of August 3, 2005 by and
among Quincy Investments Corp., a Bahamas corporation with its principal executive offices located
at 309 Terraces North, 47-111 Vintage Drive East, Indian Wells, California 92210(“Quincy”),
Naturade, Inc., a Delaware corporation with its principal executive offices located at 14370 Myford
Rd. #100, Irvine, California 92606 (“Naturade”), Symco, Incorporated, a Nevada corporation with its
principal executive offices located at 2301 West Highway 89A, Suite 107, Sedona, Arizona 86336
(“Symco”), and Symbiotics, Inc.. an Arizona corporation with its principal executive offices
located at 2301 West Highway 89A, Suite 107, Sedona, Arizona 86336 (“Symbiotics”). Quincy and
Naturade may be refered to hereinafter individually as “Licensor” and collectively as “Licensors,”
and Symco and Symbiotics may be refered to hereinafter individually as the “Licensee” and
collectively as the “Licensees.”

RECITALS

A. Quincy, Symco and Symbiotics have entered into that certain Asset Purchase Agreement, dated
as of July 22, 2005 (the “Purchase Agreement”); and Quincy, Naturade, Symco and Symbiotics have
entered into that certain Assignment and Assumption Agreement, dated of even date herewith (the
“Assignment Agreement”), pursuant to which Quincy has assigned to Naturade, and Naturade has
assumed, the rights and obligations of Quincy under the Purchase Agreement as and to the extent
provided in the Assignment Agreement.

B. As part of the transactions provided for in the Purchase Agreement and the Assignment
Agreement, Licensors transferred its right title and interest in certain assets, including
trademarks, to the Licensors.

C. Licensees desire to obtain a license with respect to a certain trademark transferred to
Licensors, and Licensors agree to grant such license to Licensees, pursuant to the provisions of
this Agreement.

D. This Agreement is the license agreement referred to in Section 2.02(g) and 2.03(e) of the
Purchase Agreement.

NOW, THEREFORE, in consideration of the transactions provided for in the Purchase Agreement
and the Assignment Agreement and the mutual provisions contained herein, the receipt and
sufficiency of which are hereby acknowledged, Licensors and Licensees (hereafter collectively
referred to as “the parties”) agree as follows:

1. Definitions. The capitalized terms used in this Agreement and not otherwise defined herein
shall have the definitions set forth in this Section1.

(a) Intellectual Property Rights. The term “Intellectual Property Rights” means all
United States and worldwide trademarks, service marks, trade names, trade dress, logos, copyrights,
rights of authorship, inventions, patents, rights of inventorship, mask works, semiconductor chip
rights, all applications, registrations and renewals in connection with any of the above, trade
secrets, rights of publicity, privacy and/or defamation, rights under unfair competition and unfair
trade practices laws, and all other intellectual and industrial property rights related thereto.

(b) Mark. The term “Mark” means the trademark “Age Defiance” which is the subject of
United States application number 78345687, as the same may be modified, enhanced or amended from
time to time, and shall include any such mark that is or becomes registered for use in the United
States.

2. Grant of License. Each Licensor hereby grants to each Licensee an irrevocable,
exclusive, perpetual (subject to Section 4), royalty-free and fully paid up, worldwide right and
license to:

(a) Use, copy, modify, create derivative marks and exploit the Mark in any manner whatsoever
related to the design, development, manufacture, use, service, support, marketing and sale of
products via multi-level marketing channels (e.g., Amway); and

(b) Sublicense any of the rights granted hereunder with the prior written consent of Naturade,
except that no such consent shall be necessary with respect to sublicense to an Affiliate (as
defined in the Purchase Agreement) of Licensee.

3. Property Rights and Related Matters.

(a) Naturade’s Rights. Subject to the rights granted hereunder to each Licensee,
Naturade shall solely own and have exclusive worldwide right, title and interest in and to the
Mark, and to all modifications, enhancements and derivative works of the Mark made by or for
Naturade, and to all Intellectual Property Rights related thereto. Licensees shall not challenge,
contest or otherwise impair Naturade’s ownership of the Mark or the validity or enforceability of
Naturade’s Intellectual Property Rights related to the Mark. Naturade has the right to modify or
make derivative works of the Mark and to otherwise exploit the Mark, subject to the rights granted
hereunder.

(b) Licensee’s Rights. Licensee shall solely own and have exclusive worldwide right,
title and interest in and to all modifications, enhancements, and derivative works with respect to
the Mark made by or for Licensee and to all Intellectual Property Rights related thereto. Naturade
shall not challenge, contest or otherwise impair Licensee’s ownership of, or the validity or
enforceability of, Licensees’ Intellectual Property Rights related thereto. Licensee has the right
to exploit, modify and make derivative works of such modifications, enhancements and derivative
works.

(c) Quality and Inspection. In order to protect the goodwill associated with the
Mark, Licensees shall use the Mark only in accordance with prevailing industry standards, for the
purpose of maintaining the quality of goods sold under the Mark. Licensees will permit duly
authorized representatives of Naturade to inspect the premises of Licensees using the Marks at all
reasonable times, for the purpose of ascertaining or determining compliance with the foregoing.
Upon Licensors’ reasonable request, Licensees shall provide Licensors with samples of products,
literature, brochures, or advertising material prepared by the Licensees for ensuring conformity
with this license. When using the Mark under this Agreement, Licensees undertake to comply
substantially with all laws pertaining to trademarks and commercial sales in force at any time,
including compliance with marking requirements.

(d) Violations or Infringements. If it comes to the attention of either Licensors or
Licensees that a third party has violated or infringed, or threatens to violate or infringe, the
Marks, each party shall immediately notify the other and request the other’s participation and
assistance to undertake all necessary and appropriate actions to terminate such violation or
infringement.

(e) Indemnification. Each party hereto shall indemnify and hold the other parties
hereto harmless from all claims, damages, liabilities, and/or lawsuits, including reasonable
attorneys’ fees, arising from or relating to the sale of their respective products using the Mark
or their Intellectual Property, or as a result of the breach of any of the material obligations
under this Agreement, including all of those set forth in this Section 3.

4. Termination.

(a) Termination. Either party shall be entitled to terminate this Agreement on thirty
(30) days’ prior written notice to the other party in the event the other party breaches a material
obligation on its part to be performed hereunder and fails to cure such material breach within
thirty (30) days of receiving written notice of such breach. Licensees’ failure to use reasonable
commercial efforts to market products under the Mark during the three year period beginning on the
date of this Agreement, or during any subsequent, rolling three-year period of this Agreement,
shall be deemed a material breach of this Agreement. In the event of any termination pursuant to
this Section 4(a), all rights in and to the Mark shall revert to the Licensors, without any payment
of consideration by Licensors, and Licensees shall thereafter cease using the Mark and have no
further rights in the Mark.

(b) Cumulative Rights and Remedies. All rights and remedies conferred upon, or
reserved to, the parties in this Agreement shall be cumulative and shall be in addition to all
other rights and remedies available to such parties at law or in equity or otherwise. Such rights
and remedies are not intended to be exclusive of any other rights or remedies and the exercise by
any party of any right or remedy herein shall be without prejudice to the exercise of any other
right or remedy by such party provided herein or available at law or in equity.

5. Miscellaneous Provisions.

(a) Relationship of Parties. The relationship between the parties is only that of a
licensor and licensee. Neither party is the agent or legal representative of the other party, and
neither party has the right or authority to bind the other party in any way. This Agreement
creates no relationship as partners or a joint venture, and creates no pooling arrangement.

(b) Governing Law and Venue. This Agreement shall be interpreted and enforced
according to the laws of the State of California, without application of its conflict of law or
choice of law rules. The parties hereto each, to the fullest extent it may effectively do so under
applicable law, irrevocably (i) submits to the exclusive jurisdiction of any court of the State of
California or the United States of America sitting in the Counties of Los Angeles or Orange over
any suit, action or proceeding arising out of or relating to this Agreement, (ii) waives and agrees
not to assert, by way of motion, as a defense or otherwise, any claim that it is not subject to the
jurisdiction of any such court, any objection that it may now or hereafter have to the
establishment of the venue of any such suit, action or proceeding brought in any such court and any
claim that any such suit, action or proceeding brought in any such court has been brought in an
inconvenient forum, and (iii) agrees that a final judgment in any such suit, action or proceeding
brought in any such court shall be conclusive and binding upon such party and may be enforced in
the courts of the United States of America or the State of California (or any other courts to the
jurisdiction of which such party is or may be subject) by a suit upon such judgment.

(c) Assignment. Neither party shall assign or transfer this Agreement (whether by
operation of law or otherwise), or any portion thereof, without the other party’s prior written
consent, except that Licensee shall have the right, without obtaining Naturade’s prior written
consent, to assign or transfer the license and rights granted to it hereunder upon providing
written notice to Naturade, to any person or entity that purchases or otherwise succeeds to all or
any part of Licensee’s assets or businesses to which the license granted to it hereunder relates
and who agrees in writing to be bound by all the terms of this Agreement.

(d) Counterparts. This Agreement may be executed in several counterparts that
together shall be originals and constitute one and the same instrument.

(e) Waiver. The failure of either party to enforce any of its rights hereunder or at
law shall not be deemed a waiver or a continuing waiver of any of its rights or remedies against
the other party, unless such failure or waiver is in writing.

(f) Severability. If any provision, or part thereof, of this Agreement is judicially
declared invalid, void or unenforceable, each and every other provision, or part thereof,
nevertheless shall continue in full force and effect, and the unenforceable provision shall be
changed or interpreted so as best to accomplish the objectives and intent of such provision within
the limits of applicable law.

(g) Attorney’s Fees. In the event a dispute arises regarding this Agreement, the
prevailing party shall be entitled to its reasonable attorney’s fees and expenses incurred in
addition to any other relief to which it is entitled.

(h) Notice. Any notice or other communication herein required or permitted to be
given shall be in writing and may be personally served or sent by facsimile or United States mail
or courier service and shall be deemed to have been given when delivered in person or by courier
service, upon receipt of facsimile, or three business days after depositing it in the United States
mail with postage prepaid and properly addressed. For the purposes hereof, the address of each
party hereto shall be as set forth in the first paragraph of this Agreement or, as to any party,
such other address as shall be designated by such party in a written notice delivered to the other
parties hereto.

(i) Further Assurances. The parties agree to execute such additional documents and
perform such acts as are reasonably necessary to effectuate the intent of this Agreement.

(j) Entire Agreement. This Agreement constitutes the entire agreement among the
parties regarding the subject matter hereof, and supersedes all prior or contemporaneous
understandings or agreements, whether oral or written, regarding the subject matter hereof. This
Agreement shall be modified or amended only by a writing signed by Naturade and Licensee.

(k) Recitals. The parties agree that each and every recital of this Agreement shall
be a covenant and agreement as well as a recital of this Agreement.

(l) Authority. The party executing this Agreement on behalf of each Licensor and
Licensee represents and warrants that such party has the authority from its respective governing
bodies to enter into this Agreement and to bind its respective company to all the terms and
conditions of this Agreement.

(m) Captions. The captions of the Sections in this Agreement are for convenience only
and shall not be used to interpret the provisions of this Agreement.

IN WITNESS WHEREOF, the parties have, through their duly authorized representatives, executed
this Agreement as of the date set forth above.

	 	 	 
	QUINCY INVESTMENTS CORP.

	 	SYMCO, INCORPORATED
	 
	 	 
	By: /s/Peter H. Pocklington

	 	By: /s/Douglas Wyatt
	NATURADE, INC.

	 	SYMBIOTICS, INC.
	By: /s/Stephen M. Kasprisin

	 	By: /s/Douglas Wyatt

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]